Error loading player: No playable sources found

Session III Discussion

Date
April 22, 2021
This product is not available for individual purchase, but it is available as part of the following products:

Panel Members

Speaker Image for Cécile Avenal
F. Hoffmann-La Roche AG
Speaker Image for Denise Gavin
CBER, FDA
Speaker Image for Katharina Künzel
Boehringer Ingelheim Pharma GmbH & Co. KG
Speaker Image for Arturo Orjalo
Genentech, a Member of the Roche Group

Related Products

Thumbnail for Enhancing the Speed of Vaccine Development by Utilizing Fully Automated High throughput Cell Potency Assays
Enhancing the Speed of Vaccine Development by Utilizing Fully Automated High throughput Cell Potency Assays
High-throughput analytical assays are one of the key enabling strategies which are needed to support vaccine development…
Thumbnail for Potency Strategy for a Fixed-Dose Combination Product
Potency Strategy for a Fixed-Dose Combination Product
A bioassay case study summarizing the challenges in setting the control system of a combination product of two highly similar monoclonal therapeutic antibodies targeting the same cellular antigen: from similar modes of action and synergistic effect to the control of each molecule bioactivity in vit…
Thumbnail for Potency Assays for Anti-virus Monoclonal Abs
Potency Assays for Anti-virus Monoclonal Abs
Viral pathogens can cause wide-spread pandemics (influenza type A, SARS-CoV-2), may have high mortality rates (Ebola virus) and pose enormous health and socioeconomic risks. Certain viruses can also be used as agents for bioterrorism…